SCHEMBL6852932

SCHEMBL6852932

OC1(c2ccc(Cl)cc2)CCN(CC/C=C2/Cc3c(CN4CCCC4)cccc3Oc3ncccc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.41
DRD4 P21917 5/20 0.39
KDM4E B2RXH2 1/20 0.39
DRD2 P14416 9/20 0.39
DRD3 P35462 5/20 0.39
CCR3 P51677 1/20 0.38
LTA4H P09960 1/20 0.37
CCR1 P32246 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37
CHRM5 P08912 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653411 1.00 HTR2A (0.41) HTR2ADRD4KDM4EDRD2DRD3
SCHEMBL654486 0.99 HTR2A (0.42) HTR2ADRD4KDM4EDRD2DRD3
SCHEMBL654976 0.92 DRD2 (0.39) HTR2ADRD4DRD2DRD3CCR3
SCHEMBL654978 0.92 DRD2 (0.39) HTR2ADRD4DRD2DRD3CCR3
SCHEMBL653953 0.91 DRD2 (0.40) HTR2ADRD4DRD2CCR1ADRA1A
SCHEMBL653951 0.91 DRD2 (0.40) HTR2ADRD4DRD2CCR1ADRA1A
SCHEMBL655932 0.90 DRD2 (0.38) HTR2ADRD4DRD2DRD3CCR3
SCHEMBL652406 0.89 DRD2 (0.38) HTR2ADRD4DRD2CCR3CCR1
SCHEMBL652404 0.89 DRD2 (0.38) HTR2ADRD4DRD2CCR3CCR1
SCHEMBL653964 0.89 DRD2 (0.40) HTR2ADRD4DRD2CCR3CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 WO disclosed